Quarterly Activities/Appendix 4C Cash Flow Report

Open PDF
Stock Delorean Corporation Ltd (DEL.ASX)
Release Time 30 Apr 2026, 9:14 a.m.
Price Sensitive Yes
 Delorean reports Q3 FY2026 activities
Key Points
  • Cash balance of $7.2 million as at 31 March 2026
  • Strong construction progress on SA1 Salisbury project, with $1.1 million ARENA grant received
  • Final Investment Decision reached for NSW1 Horsley Park Bioenergy facility, supported by $30.5 million in grants
Full Summary

Delorean Corporation Limited (ASX: DEL) has reported on its activities for the March 2026 quarter (Q3 FY2026). The company's cash balance stood at $7.2 million as at 31 March 2026, excluding future grants and R&D Tax refund receivables. Receipts from customers were $0.8 million for the quarter. Strong construction progress continued on Delorean's flagship SA1 Salisbury project, with key infrastructure including reception shed, weighbridge, and critical equipment installation advancing. The company achieved its second ARENA milestone, receiving a further $1.1 million grant payment. Subsequent to the quarter, Delorean welcomed Bradley O'Malley as General Manager for the SA1 Salisbury project. In April 2026, the Delorean Board reached a positive Final Investment Decision for its 100%-owned NSW1 Horsley Park Bioenergy facility, supported by $30.5 million in secured grants. The proposed facility will supply renewable natural gas to Brickworks under a long-term offtake agreement. Delorean also continued to advance the development of the VIC1 Stanhope Bioenergy project, progressing towards Final Investment Decision in 2H FY2026. Additionally, the company entered into a strategic partnership with Opal to assess the viability of anaerobic digestion facilities, commencing at Opal's Paper Mill in Victoria.